Dieuwke Hooft Graafland
Loyens & LoeffThe team at Loyens & Loeff acts for a lucrative, varied client base of healthcare insurance, diagnostics, and pharma companies on an array of regulatory, corporate, and tax related matters. The group regularly represents clients in administrative proceedings involving alleged breaches of transparency laws within the healthcare procurement process. Tom van Helmond, Kim Lucassen, and Vincent van der Lans jointly head the practice. Lucassen is well known for her expansive expertise in data protection and cybersecurity, advising a number of biotech companies and research institutions, while van Helmond is noted for his vast knowledge of procurement and competition issues and van der Lans maintains a tax-focused practice that encompasses a range of financing transactions and M&A. Regulatory expert Dieuwke Hooft Graafland handles a broad range of healthcare disputes concerning insurance and financing, in addition to advising on joint ventures and corporate governance. Céline van Waesberge left the team in June 2023.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Approachable, fast, excellent quality.’
‘Dieuwke Hooft Graafland is approachable, fast, delivers excellent quality, and is familiar with our company.’
‘The team excels in their expertise and willingness to help out.’
‘I work with Kim Lucassen on a regular basis, she has a very good knowledge of the life sciences sector. She is very pragmatic.’
‘Pleasant, knowledgeable, approachable, accessible and fast working team.’
Key clients
- AstraZeneca
- Zilveren Kruis
- Unilabs
- Bergman Clinics
- Zorgverzekeraars Nederland
- European Investment Bank
- Forbion
- VGZ
- Hartwig Medical Foundation
- Laurens
- EQT
- Menzis
- Amstelland Hospital
- Medtronic
- Orpea
- Galapagos
Work highlights
- Advised AstraZeneca on Dutch legal (including life sciences regulatory), employment, and tax matters in connection with the acquisition of Neogene Therapeutics Inc., a global clinical-stage biotechnology company which will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam and California.
- Represented Zilveren Kruis in landmark procedures concerning the so-called impediment criterion, a case which the client won.
- Assisted Unilabs Nederland B.V. with the acquisition of Laboratorium-Centrum voor Bedrijven (L.C.B.) and Atalmedial Holding B.V. from Stichting Atalmedial.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Tom van Helmond
Loyens & LoeffPractice head
The lawyer(s) leading their teams.
Tom van Helmond, Kim Lucassen, Vincent van der Lans